Lawrence Laslett
About
In The Last Decade
Lawrence Laslett
39 papers receiving 935 citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Cardiology and Cardiovascular Medicine 518
- Surgery 253
- Radiology, Nuclear Medicine and Imaging 136
- Complementary and alternative medicine 123
- Pulmonary and Respiratory Medicine 103
Countries citing papers authored by Lawrence Laslett
This map shows the geographic impact of Lawrence Laslett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Laslett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Laslett more than expected).
Fields of papers citing papers by Lawrence Laslett
This network shows the impact of papers produced by Lawrence Laslett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Laslett. The network helps show where Lawrence Laslett may publish in the future.
Co-authorship network of co-authors of Lawrence Laslett
This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Laslett. A scholar is included among the top collaborators of Lawrence Laslett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Laslett. Lawrence Laslett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | The Worldwide Environment of Cardiovascular Disease: Prevalence, Diagnosis, Therapy, and Policy Issues breakdown → | 559 |
| 3 | 21 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 29 | |
| 7 | 15 | |
| 8 | 16 | |
| 9 | 42 | |
| 10 | 3 | |
| 11 | 10 | |
| 12 | 22 | |
| 13 | 5 | |
| 14 | 2 | |
| 15 | 14 | |
| 16 | 13 | |
| 17 | 2 | |
| 18 | 11 | |
| 19 | Prolonged afterload reduction and cardiac output augmentation by oral prazosin in acute myocardial infarction with congestive heart failure | 1 |
| 20 | Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy. | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.